Thursday, 28 January 2021

Diplomat inks exclusive practice-based infusion contract with Allergy Partners

12 August 2019 | News

This innovative agreement forms the nation's first large-scale physician practice-based infusion program

Diplomat Pharmacy, is pleased to announce an exclusive agreement between Diplomat and Allergy Partners, P.A., to manage in-office and in-home delivery and administration of infusion drugs and biologics. The agreement will cover treatments for primary immunodeficiency, alpha-1 antitrypsin deficiency, hereditary angioedema, and more.

Allergy Partners is the nation's largest independent, single-specialty practice for allergic disease, asthma, and immunology. Their fast-growing national network consists of 161 providers across 128 locations and 20 states.

The five-year agreement, which includes renewal provisions, should allow both organizations to leverage their consolidated purchase volume within the growing marketplace for allergy and immunology biologics. It also creates a unique and preeminent treatment platform for patients that supports both companies' core value of putting patients first.

Under this management agreement, Diplomat will provide clinical oversight and staffing, nursing services, information technology, materials management, reimbursement, and certain finance and accounting services on behalf of Allergy Partners' 128 practice locations.

The agreement includes the integration of both parties' information technology platforms to support close care coordination between Allergy Partners' physicians and the pharmacy and nursing service teams that Diplomat will be managing.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls